-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
PSYCHEMEDICS CORP quarterly/annual Deferred Income Tax Expense (Benefit) history and change rate from 2010 to 2024.
- PSYCHEMEDICS CORP Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $0.000.
- PSYCHEMEDICS CORP annual Deferred Income Tax Expense (Benefit) for 2024 was $0.000, a 100% decline from 2023.
- PSYCHEMEDICS CORP annual Deferred Income Tax Expense (Benefit) for 2023 was $692K.
- PSYCHEMEDICS CORP annual Deferred Income Tax Expense (Benefit) for 2022 was -$531K, a 43.1% decline from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)